Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry

Cancer Science

Volumn 106, Issue 5, 2015, Pages 598-603

  Kobayashi, Seiichiro ^a   Watanabe, Eri ^a   Ishigaki, Tomohiro ^a   Ohno, Nobuhiro ^a   Yuji, Koichiro ^a   Nakano, Kazumi ^b   Yamochi, Tadanori ^b   Watanabe, Nobukazu ^a   Tojo, Arinobu ^a   Watanabe, Toshiki ^b   Uchimaru, Kaoru ^a  

^a THE UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adult T cell leukemia lymphoma; CADM1 protein; CD7 antigen; Flow cytometry; HTLV 1

Indexed keywords

CD7 ANTIGEN; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE 1; GLYCOPROTEIN; UNCLASSIFIED DRUG; CADM1 PROTEIN, HUMAN; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; BLOOD; CANCER RISK; CLINICAL ARTICLE; CLONAL VARIATION; DISEASE CARRIER; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY CANCER; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; LYMPHOCYTE; MALE; PRIORITY JOURNAL; T CELL LEUKEMIA; VIRUS LOAD; HUMAN T CELL LEUKEMIA VIRUS INFECTION; ISOLATION AND PURIFICATION; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; PROCEDURES; VIROLOGY;

ADULT; AGED; ANTIGENS, CD7; CELL ADHESION MOLECULES; FEMALE; FLOW CYTOMETRY; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOGLOBULINS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOCYTES; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84929706479     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12639     Document Type: Article

References (27)

1. Mochizuki M, Watanabe T, Yamaguchi K et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992; 83: 236-9.
2. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 1982; 79: 2031-5.
3. Osame M, Usuku K, Izumo S et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031-2.
4. Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol 2012; 3: 388.
5. Yamaguchi K, Watanabe T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int J Hematol 2002; 76(Suppl 2): 240-5.
6. Murphy EL, Hanchard B, Figueroa JP et al. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 1989; 43: 250-3.
7. Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol 2012; 3: 322.
8. Tian Y, Kobayashi S, Ohno N et al. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer Sci 2011; 102: 569-77.
9. Kobayashi S, Tian Y, Ohno N et al. The CD3 versus CD7 Plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I. PLoS ONE 2013; 8: e53728.
10. Kobayashi S, Nakano K, Watanabe E et al. CADM1 expression and stepwise downregulation of CD7 are closely associated with clonal expansion of HTLV-I-infected cells in adult t-cell leukemia/lymphoma. Clin Cancer Res 2014; 20: 2851-61.
11. Hisada M, Okayama A, Shioiri S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998; 92: 3557-61.
12. Iwanaga M, Watanabe T, Utsunomiya A et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010; 116: 1211-9.
13. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991; 79: 428-37.
14. Tsukasaki K, Hermine O, Bazarbachi A et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27: 453-9.
15. Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR. HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 2012; 120: 3488-90.
16. Ishida T, Joh T, Uike N et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 2012; 30: 837-42.
17. Nakahata S, Saito Y, Marutsuka K et al. Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma. Leukemia 2012; 26: 1238-46.
18. Sasaki H, Nishikata I, Shiraga T et al. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 2005; 105: 1204-13.
19. Yamagishi M, Nakano K, Miyake A et al. Polycomb-mediated loss of miR-31 activates NIK-dependent NF-kappaB pathway in adult T cell leukemia and other cancers. Cancer Cell 2012; 21: 121-35.
20. Kamihira S, Iwanaga M, Doi Y et al. Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL. Int J Hematol 2012; 95: 399-408.
21. Sasaki D, Doi Y, Hasegawa H et al. High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders. Virol J 2010; 7: 81.
22. Wattel E, Vartanian JP, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995; 69: 2863-8.
23. Yoshida M, Seiki M, Yamaguchi K, Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 1984; 81: 2534-7.
24. Gillet NA, Malani N, Melamed A et al. The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones. Blood 2011; 117: 3113-22.
25. Cook LB, Melamed A, Niederer H et al. The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphoma. Blood 2014; 123: 3925-31.
26. Firouzi S, Lopez Y, Suzuki Y et al. Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites. Genome Med 2014; 6: 46.
27. Tsukasaki K, Imaizumi Y, Tawara M et al. Diversity of leukaemic cell morphology in ATL correlates with prognostic factors, aberrant immunophenotype and defective HTLV-1 genotype. Br J Haematol 1999; 105: 369-75.